Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP312315.RAdsGzWGwelwR8D0Ca_f0EHWTIu0yMs5v8PEw_5-ylpro130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312315.RAdsGzWGwelwR8D0Ca_f0EHWTIu0yMs5v8PEw_5-ylpro130_provenance.
• NP570962.RAUUGapfQLk_KNNmKsrg8exFEFfc2J7lrr6xx-oFi2PHY130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570962.RAUUGapfQLk_KNNmKsrg8exFEFfc2J7lrr6xx-oFi2PHY130_provenance.
• NP571422.RAVaeJHSMBqCKYAFnprbgNG8Vg1D3q0cdYUGeZQjsZNb8130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571422.RAVaeJHSMBqCKYAFnprbgNG8Vg1D3q0cdYUGeZQjsZNb8130_provenance.
• assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP895300.RAX_ITNsICpmzDWvMNKqCLlu3GE1jKzyh-XHyvGtBJWUk130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895300.RAX_ITNsICpmzDWvMNKqCLlu3GE1jKzyh-XHyvGtBJWUk130_provenance.
• NP895307.RAeBZB5HPtMeG_-l-veMFO4pcUOciW0gWz4Mj9zoMp5SQ130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895307.RAeBZB5HPtMeG_-l-veMFO4pcUOciW0gWz4Mj9zoMp5SQ130_provenance.
• NP895311.RAa04s6JABKwfEdC4pLVlYDGvO7A90sDkOuhj__spR7f8130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895311.RAa04s6JABKwfEdC4pLVlYDGvO7A90sDkOuhj__spR7f8130_provenance.
• NP309319.RACyJN2P1KGz5CHS3-Io-bnGVqKkXN-HjLRIWyT9uaP-U130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309319.RACyJN2P1KGz5CHS3-Io-bnGVqKkXN-HjLRIWyT9uaP-U130_provenance.
• assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP895296.RAA7DfPzDd7V_FbDJNqJkQmpVFfl1Gfy5xy7EI0Gfiugk130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895296.RAA7DfPzDd7V_FbDJNqJkQmpVFfl1Gfy5xy7EI0Gfiugk130_provenance.
• NP895309.RADGu2CalQT1FF7HxdPR4malQ5IWGYBZW97GpaPsu6sKk130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895309.RADGu2CalQT1FF7HxdPR4malQ5IWGYBZW97GpaPsu6sKk130_provenance.
• NP959799.RAmFemFGUwIx7AtqUSzMMAlrBGRAp1C5ubRoCB80kbK1Y130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP959799.RAmFemFGUwIx7AtqUSzMMAlrBGRAp1C5ubRoCB80kbK1Y130_provenance.
• NP954421.RAmMBovxBknH6oXSbXU1flcX-dTTbPSwBx9ClG6tupMao130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954421.RAmMBovxBknH6oXSbXU1flcX-dTTbPSwBx9ClG6tupMao130_provenance.
• NP895306.RAjeAGwYJ5mKUYpnXNXdyvNi7_MPk3hKN_ePsFz_bqd0s130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895306.RAjeAGwYJ5mKUYpnXNXdyvNi7_MPk3hKN_ePsFz_bqd0s130_provenance.
• NP312033.RAEkkW8V38AZksoJGnFUe9ao5mvLSQDnxbvVrdsz_u2Io130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312033.RAEkkW8V38AZksoJGnFUe9ao5mvLSQDnxbvVrdsz_u2Io130_provenance.
• NP651278.RAP3FtfByT6fbp3jsZUIz46mK3L4YoC8r1GUKZ_91vXvs130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651278.RAP3FtfByT6fbp3jsZUIz46mK3L4YoC8r1GUKZ_91vXvs130_provenance.
• NP895305.RAM3qTSbgWnX28f0Llug32crXh2EulOcYRmUcxCUcs5Ns130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895305.RAM3qTSbgWnX28f0Llug32crXh2EulOcYRmUcxCUcs5Ns130_provenance.
• NP895301.RAwAQyFT79D2ZjcGeoC6sfTq_htoQcviWy0qIm9Sgx0fg130_assertion description "[Moreover, the combination of the OS-MSP assay and the assay involving CEA and/or CA15-3 is promising for enhancing the sensitivity of diagnosis of metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895301.RAwAQyFT79D2ZjcGeoC6sfTq_htoQcviWy0qIm9Sgx0fg130_provenance.